Style | Citing Format |
---|---|
MLA | Feily A, Daneshpay K, Alighadr A. "Covid-19: Pentoxifylline As a Potential Adjuvant Treatment." International Journal of Clinical Pharmacology and Therapeutics, vol. 58, no. 7, 2020, pp. 406-407. |
APA | Feily A, Daneshpay K, Alighadr A (2020). Covid-19: Pentoxifylline As a Potential Adjuvant Treatment. International Journal of Clinical Pharmacology and Therapeutics, 58(7), 406-407. |
Chicago | Feily A, Daneshpay K, Alighadr A. "Covid-19: Pentoxifylline As a Potential Adjuvant Treatment." International Journal of Clinical Pharmacology and Therapeutics 58, no. 7 (2020): 406-407. |
Harvard | Feily A, Daneshpay K, Alighadr A (2020) 'Covid-19: Pentoxifylline As a Potential Adjuvant Treatment', International Journal of Clinical Pharmacology and Therapeutics, 58(7), pp. 406-407. |
Vancouver | Feily A, Daneshpay K, Alighadr A. Covid-19: Pentoxifylline As a Potential Adjuvant Treatment. International Journal of Clinical Pharmacology and Therapeutics. 2020;58(7):406-407. |
BibTex | @article{ author = {Feily A and Daneshpay K and Alighadr A}, title = {Covid-19: Pentoxifylline As a Potential Adjuvant Treatment}, journal = {International Journal of Clinical Pharmacology and Therapeutics}, volume = {58}, number = {7}, pages = {406-407}, year = {2020} } |
RIS | TY - JOUR AU - Feily A AU - Daneshpay K AU - Alighadr A TI - Covid-19: Pentoxifylline As a Potential Adjuvant Treatment JO - International Journal of Clinical Pharmacology and Therapeutics VL - 58 IS - 7 SP - 406 EP - 407 PY - 2020 ER - |